ateganosine
SCCC-12225; STU20251351
Phase 1 small_molecule active
Quick answer
ateganosine for Resectable Hepatocellular Carcinoma is a Phase 1 program (small_molecule) at MAIA Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MAIA Biotechnology
- Indication
- Resectable Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active